Pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in cynomolgus monkeys
- 6 July 2013
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 386 (11) , 1001-1008
Abstract
Mirabegron is a novel β3-adrenoceptor agonist developed for the treatment of overactive bladder. To clarify the relationship between the pharmacological effects of mirabegron in monkeys and the clinical efficacy in patients with overactive bladder, the effect of mirabegron on bladder function was evaluated using cynomolgus monkeys. Quantitative PCR revealed that mRNA expression of β3-adrenoceptors was most abundant (98 %) among β-adrenoceptor subtypes in the bladder of cynomolgus monkeys. Mirabegron, which showed selective and potent agonistic activity on monkey β3-adrenoceptors expressed in Chinese hamster ovary cells with EC50 value of 32 nmol/L and intrinsic activity of 0.8, induced concentration-dependent relaxation of bladder smooth muscle strips isolated from cynomolgus monkeys with EC50 values of 120 nmol/L in 20 mmol/L KCl stimulation and 43 nmol/L under 9.81 mN resting tension. In conscious cynomolgus monkeys, mirabegron decreased micturition frequency at oral doses of 1 and 3 mg/kg and increased mean volume voided per micturition at an oral dose of 3 mg/kg. Plasma concentration at which bladder function improved in the cynomolgus monkeys was similar to that at the clinically effective dose in patients with overactive bladder. These data suggest that the relaxant function in monkey bladder is mainly mediated by β3-adrenoceptors similar to that in the human bladder and mirabegron showed efficacy on the bladder functions of the same parameters in clinical evaluation endpoints.Keywords
This publication has 23 references indexed in Scilit:
- Effects of a novel β3‐adrenoceptor agonist, AJ‐9677, on relaxation of the detrusor muscle: Anin vitrostudyInternational Journal of Urology, 2008
- Effect of (R)-2-(2-Aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} Acetanilide (YM178), a Novel Selective β3-Adrenoceptor Agonist, on Bladder FunctionThe Journal of Pharmacology and Experimental Therapeutics, 2007
- A Quantitative Analysis of mRNA Expression of α1 and β-adrenoceptor Subtypes and Their Functional Roles in Human Normal and Obstructed BladdersJournal of Urology, 2003
- β3-adrenoceptors in human detrusor muscleUrology, 2002
- Characterization of β-Adrenoceptor Subtype in Bladder Smooth Muscle in Cynomolgus MonkeyThe Japanese Journal of Pharmacology, 2002
- Characterization of β-adrenoceptor subtypes in the ferret urinary bladder in vitro and in vivoEuropean Journal of Pharmacology, 2000
- Functional and molecular biological evidence for a possible β3‐adrenoceptor in the human detrusor muscleBritish Journal of Pharmacology, 1999
- Species differences in the distribution of β‐adrenoceptor subtypes in bladder smooth muscleBritish Journal of Pharmacology, 1998
- EXPRESSION OF beta 3-ADRENOCEPTORS IN RAT DETRUSOR SMOOTH MUSCLEJournal of Urology, 1998
- Autonomic Receptor Function in the Lower Urinary Tract of Man and CatScandinavian Journal of Urology and Nephrology, 1972